Form 8-K - Current report:
SEC Accession No. 0001326110-24-000093
Filing Date
2024-07-18
Accepted
2024-07-17 21:48:07
Documents
13
Period of Report
2024-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K ibrx-20240713.htm   iXBRL 8-K 36346
  Complete submission text file 0001326110-24-000093.txt   163950

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20240713.xsd EX-101.SCH 1926
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20240713_lab.xml EX-101.LAB 21876
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20240713_pre.xml EX-101.PRE 12528
15 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20240713_htm.xml XML 2718
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 241123610
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)